MX2009008760A - Composicion para el tratamiento de enfermedades del cartilago. - Google Patents
Composicion para el tratamiento de enfermedades del cartilago.Info
- Publication number
- MX2009008760A MX2009008760A MX2009008760A MX2009008760A MX2009008760A MX 2009008760 A MX2009008760 A MX 2009008760A MX 2009008760 A MX2009008760 A MX 2009008760A MX 2009008760 A MX2009008760 A MX 2009008760A MX 2009008760 A MX2009008760 A MX 2009008760A
- Authority
- MX
- Mexico
- Prior art keywords
- cartilage
- composition
- effect
- treatment
- inflammation
- Prior art date
Links
- 208000015100 cartilage disease Diseases 0.000 title abstract 3
- 230000000694 effects Effects 0.000 abstract 5
- 210000000845 cartilage Anatomy 0.000 abstract 4
- 206010061218 Inflammation Diseases 0.000 abstract 3
- 230000004054 inflammatory process Effects 0.000 abstract 3
- 230000008929 regeneration Effects 0.000 abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 2
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 210000005067 joint tissue Anatomy 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe una composición para la regeneración de un cartílago, o el tratamiento de una enfermedad del cartílago, la cual comprende, como un ingrediente activo, una sal de metal univalente de ácido algínico que tiene un nivel reducido de endotoxinas a un grado tal que no induzca sustancialmente una inflamación o ataque de fiebre. Se hace posible proporcionar: una composición para la regeneración de un cartílago, el cual mejora en actividad regeneradora de cartílago y posibilidad de aplicación a un área dañada del cartílago; y una composición par el tratamiento de una enfermedad del cartílago, la cual tiene todo un efecto de proteger un cartílago de un estímulo mecánico, un efecto de prevenir la deformación del cartílago por desgaste o inflamación, un efecto de reparar una parte dañada del cartílago, y un efecto de prevenir una inflamación o dolor en un tejido articular.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007041520 | 2007-02-21 | ||
| JP2007277005 | 2007-10-24 | ||
| PCT/JP2008/052999 WO2008102855A1 (ja) | 2007-02-21 | 2008-02-21 | 軟骨疾患治療用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009008760A true MX2009008760A (es) | 2009-08-27 |
Family
ID=39710126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009008760A MX2009008760A (es) | 2007-02-21 | 2008-02-21 | Composicion para el tratamiento de enfermedades del cartilago. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8372394B2 (es) |
| EP (2) | EP2127687B1 (es) |
| JP (2) | JP4740369B2 (es) |
| KR (1) | KR101440170B1 (es) |
| CN (2) | CN104906126B (es) |
| AU (1) | AU2008217916B2 (es) |
| BR (1) | BRPI0807739B1 (es) |
| CA (2) | CA2677436C (es) |
| ES (1) | ES2637163T3 (es) |
| IL (2) | IL200342A (es) |
| MX (1) | MX2009008760A (es) |
| NZ (2) | NZ578985A (es) |
| WO (1) | WO2008102855A1 (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2801355T3 (pl) * | 2004-10-08 | 2015-10-30 | Fwp Ip Aps | Kompozycje farmaceutycznie o kontrolowanym uwalnianiu zawierające ester kwasu fumarowego |
| CN104906126B (zh) * | 2007-02-21 | 2019-05-28 | 持田制药株式会社 | 用于治疗软骨疾病的组合物 |
| ES2479541T1 (es) * | 2008-12-19 | 2014-07-24 | Cellerix, S.A. | Micropartículas que comprenden células madre de tejido adiposo |
| WO2011031642A2 (en) * | 2009-09-08 | 2011-03-17 | Musculoskeletal Transplant Foundation Inc. | Tissue engineered meniscus repair composition |
| WO2011031637A2 (en) * | 2009-09-08 | 2011-03-17 | Musculoskeletal Transplant Foundation Inc. | Tissue engineered meniscus repair composition |
| WO2012085609A1 (en) * | 2010-12-20 | 2012-06-28 | Dept. Of Pathobiology | Treatment of osteoarthritis by continuous intra-articular injection of alginate gel |
| US20140213524A1 (en) * | 2011-08-23 | 2014-07-31 | National University Corporation Hokkaido University | Composition for regeneration of cartilage |
| US10016527B2 (en) * | 2012-10-23 | 2018-07-10 | Orthovita, Inc. | Materials and methods for repair of cartilage defects |
| US9616093B2 (en) * | 2013-01-30 | 2017-04-11 | NuTech Medical, Inc. | Placental membrane preparation and methods of making and using same |
| WO2015162929A1 (ja) * | 2014-04-24 | 2015-10-29 | 国立大学法人北海道大学 | 潜熱蓄熱体、潜熱蓄熱体の製造方法、および、熱交換材料 |
| EP3151848A4 (en) * | 2014-06-06 | 2018-01-24 | Vivoscript, Inc. | Methods for repairing cartilage damage |
| GB201412236D0 (en) * | 2014-07-09 | 2014-08-20 | Univ Nottingham | Method of producing and using alginate hydrogels |
| WO2016073989A2 (en) * | 2014-11-07 | 2016-05-12 | The Trustees Of Columbia University In The City Of New York | Osteochondroreticular stem cells for bone and cartilage regeneration |
| CN106344595B (zh) * | 2015-07-17 | 2020-06-19 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用 |
| KR102740598B1 (ko) | 2015-09-07 | 2024-12-09 | 모찌다 세이야쿠 가부시끼가이샤 | 알긴산 동결 건조 제제 |
| WO2017163603A1 (ja) * | 2016-03-23 | 2017-09-28 | 国立大学法人北海道大学 | 椎間板治療用組成物 |
| EP3506946A1 (en) * | 2016-09-05 | 2019-07-10 | Association for the Advancement of Tissue Engineering and Cell based Technologies & Therapies (A4TEC) - Associação | Kefiran for use in regenerative medicine and/or tissue engineering |
| CN110520165A (zh) * | 2017-03-02 | 2019-11-29 | 持田制药株式会社 | 纤维软骨组织损伤治疗用组合物 |
| WO2018164128A1 (ja) | 2017-03-07 | 2018-09-13 | 持田製薬株式会社 | アルギン酸液剤 |
| US11872328B2 (en) * | 2017-08-30 | 2024-01-16 | Hadasit Medical Research Services And Development Ltd. | Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions |
| US11406612B2 (en) | 2018-02-26 | 2022-08-09 | Rensselaer Polytechnic Institute | Method of treatment via intra-articular application of potassium |
| WO2019182015A1 (ja) | 2018-03-22 | 2019-09-26 | 持田製薬株式会社 | 非ステロイド性抗炎症性化合物結合アルギン酸誘導体 |
| WO2020045162A1 (ja) * | 2018-08-30 | 2020-03-05 | 学校法人慶應義塾 | 薬物送達用担体 |
| ES3043132T3 (en) * | 2019-08-01 | 2025-11-24 | Medicrinia Co Ltd | Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury |
| US12491208B2 (en) | 2020-01-14 | 2025-12-09 | Mochida Pharmaceutical Co., Ltd. | Combination and method for treating subject using alginate |
| JP2021109006A (ja) * | 2020-01-14 | 2021-08-02 | 持田製薬株式会社 | 注入装置 |
| US20230080690A1 (en) * | 2020-01-17 | 2023-03-16 | National University Corporation Hokkaido University | Cartilage damage treatment material utilizing bone marrow fluid |
| KR102587871B1 (ko) * | 2020-06-19 | 2023-10-12 | 숙명여자대학교산학협력단 | Bmpr2 유전자 기능획득 돌연변이체를 포함하는 돌연변이 복합체 및 이의 용도 |
| JPWO2022102093A1 (es) | 2020-11-13 | 2022-05-19 | ||
| WO2024136537A1 (ko) * | 2022-12-23 | 2024-06-27 | 주식회사 삼양홀딩스 | 조직 수복용 건조 제형 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985000332A1 (en) * | 1983-07-11 | 1985-01-31 | Donald Earl Burg | Flexible bow seal air ride boat hull |
| US5589591A (en) | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
| JPH0513136A (ja) | 1991-06-28 | 1993-01-22 | Nec Corp | Ｉｃソケツト |
| WO1993013136A1 (en) | 1991-12-20 | 1993-07-08 | Howmedica Inc. | Ultra-pure polysaccharide materials for medical use |
| US5266326A (en) * | 1992-06-30 | 1993-11-30 | Pfizer Hospital Products Group, Inc. | In situ modification of alginate |
| JPH08269102A (ja) | 1995-03-30 | 1996-10-15 | Shiseido Co Ltd | エンドトキシンフリーのβ１，３−グルカン及びその製造法並びに医療用ゲル素材 |
| JPH09324001A (ja) | 1996-04-02 | 1997-12-16 | Kyowa Hakko Kogyo Co Ltd | ヒアルロン酸ナトリウムの精製法 |
| JPH10101577A (ja) * | 1996-09-27 | 1998-04-21 | Nikken Chem Co Ltd | 関節可動域低下症の予防・治療薬 |
| JP4002299B2 (ja) * | 1996-12-10 | 2007-10-31 | セラマット・インコーポレーテッド | 組織処理用の改善されたヒドロゲル |
| CA2304093A1 (en) | 1997-09-19 | 1999-04-01 | Reprogenesis, Inc. | Improved hydrogel for tissue engineering |
| WO2000029449A1 (en) | 1998-11-13 | 2000-05-25 | Cp Kelco U.S. Inc. | Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same |
| WO2002055073A1 (en) * | 2001-01-05 | 2002-07-18 | Kyowa Kakko Kogyo Co., Ltd. | Preventives for arthritis |
| TW200307011A (en) | 2002-04-18 | 2003-12-01 | Chugai Pharmaceutical Co Ltd | Hyaluronic acid modifier |
| JPWO2003099339A1 (ja) | 2002-05-29 | 2005-09-22 | アンジェスＭｇ株式会社 | 炎症性疾患を処置および予防するためのデコイ組成物 |
| JP2005036036A (ja) | 2003-07-16 | 2005-02-10 | Tanabe Seiyaku Co Ltd | エンドトキシン除去方法 |
| AU2005295927B2 (en) * | 2004-10-12 | 2012-02-02 | Fmc Biopolymer As | Self-gelling alginate systems and uses thereof |
| TWI290651B (en) | 2005-07-29 | 2007-12-01 | Optimax Tech Corp | A method for manufacturing a light compensation film, and a polarizer having the light compensation film |
| JP4986273B2 (ja) | 2005-09-15 | 2012-07-25 | 持田製薬株式会社 | アルギン酸を含む創傷被覆材 |
| JP4838178B2 (ja) | 2006-03-17 | 2011-12-14 | 京セラミタ株式会社 | 画像形成装置 |
| CN104906126B (zh) * | 2007-02-21 | 2019-05-28 | 持田制药株式会社 | 用于治疗软骨疾病的组合物 |
-
2008
- 2008-02-21 CN CN201510202005.7A patent/CN104906126B/zh not_active Expired - Fee Related
- 2008-02-21 CA CA2677436A patent/CA2677436C/en not_active Expired - Fee Related
- 2008-02-21 ES ES08720791.6T patent/ES2637163T3/es active Active
- 2008-02-21 BR BRPI0807739-8A patent/BRPI0807739B1/pt not_active IP Right Cessation
- 2008-02-21 CN CN200880004925.6A patent/CN101951969B/zh not_active Expired - Fee Related
- 2008-02-21 CA CA2912930A patent/CA2912930C/en not_active Expired - Fee Related
- 2008-02-21 JP JP2009500239A patent/JP4740369B2/ja active Active
- 2008-02-21 US US12/311,426 patent/US8372394B2/en active Active
- 2008-02-21 KR KR1020097016862A patent/KR101440170B1/ko not_active Expired - Fee Related
- 2008-02-21 EP EP08720791.6A patent/EP2127687B1/en active Active
- 2008-02-21 NZ NZ578985A patent/NZ578985A/en not_active IP Right Cessation
- 2008-02-21 EP EP17157935.2A patent/EP3189859B8/en active Active
- 2008-02-21 AU AU2008217916A patent/AU2008217916B2/en not_active Ceased
- 2008-02-21 NZ NZ596105A patent/NZ596105A/xx not_active IP Right Cessation
- 2008-02-21 WO PCT/JP2008/052999 patent/WO2008102855A1/ja not_active Ceased
- 2008-02-21 MX MX2009008760A patent/MX2009008760A/es active IP Right Grant
-
2009
- 2009-08-11 IL IL200342A patent/IL200342A/en active IP Right Grant
-
2011
- 2011-04-28 JP JP2011101107A patent/JP5425134B2/ja active Active
-
2013
- 2013-01-09 US US13/737,171 patent/US9216201B2/en active Active
-
2014
- 2014-01-06 IL IL230335A patent/IL230335A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009008760A (es) | Composicion para el tratamiento de enfermedades del cartilago. | |
| MX2010004484A (es) | Composicion para tratamiento de enfermedad de las articulaciones. | |
| WO2015009991A3 (en) | Methods, systems, and compositions for promoting bone growth | |
| WO2010151338A3 (en) | Myostatin inhibitor enhancement of musculoskeletal repair | |
| MX2010006519A (es) | Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina. | |
| WO2010071826A3 (en) | Methods for treating osteoclast-related disease, compounds and compositions thereof | |
| MX337614B (es) | Tratamiento de lupus nefritis usando laquinimod. | |
| EA201891507A1 (ru) | Кислая альфа-глюкозидаза усиленного действия для лечения болезни помпе | |
| EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
| EA200900203A1 (ru) | Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение | |
| EA201001865A1 (ru) | Противовоспалительные агенты | |
| EA201290859A1 (ru) | Лечение люпус-артрита с использованием лаквинимода | |
| WO2010081091A3 (en) | Therapeutic compositions for treatment of corneal disorders | |
| TW200806299A (en) | Treatment of pain | |
| TW200724543A (en) | Heterocyclic compounds and their uses as therapeutic agents | |
| MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
| ATE538775T1 (de) | Ketorolac-tromethamin-zusammensetzungen zur behandlung oder prävention von schmerz | |
| MX2013008729A (es) | Metodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales. | |
| MY168759A (en) | Pharmaceutical compositions comprising modified fucans and methods relating thereto | |
| BR112014006473A2 (pt) | composição e método para tratamento de uma doença autoimune | |
| WO2007120485A3 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
| EA024696B9 (ru) | Способ обработки волос | |
| MY156691A (en) | 2-(r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline from 1 | |
| WO2008073466A3 (en) | Alpha b-crystallin as a therapy for inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |